Biogenic and facile synthesis of selenium nanoparticles using Vaccinium arctostaphylos L. fruit extract and anticancer activity against in vitro model of breast cancer

Cell Biol Int. 2022 Oct;46(10):1612-1624. doi: 10.1002/cbin.11852. Epub 2022 Jul 12.

Abstract

Biogenic synthesis of selenium nanoparticles (SeNPs) using plant extracts has emerged as a promising alternative approach to traditional chemical synthesis. The current study aims to introduce a safe, low-cost, and green synthesis of SeNPs using fresh fruit extract of Vaccinium arctostaphylos L. The biogenic synthesis of SeNPs was confirmed by different analyses including ultraviolet-visible spectrophotometry, Fourier transform infrared, and energy-dispersive X-ray. Also, the crystalline nature, size, and morphology of the obtained SeNPs were characterized by X-ray diffraction, dynamic light scattering, field emission scanning electron microscopy, and transmission electron microscopy techniques. The SeNPs were successfully synthesized with fruit extract of V. arctostaphylos L. in a regular spherical form and narrow size distribution with suitable zeta-potential values and exhibited appropriate biocompatibility. It revealed that the synthesized SeNPs can significantly inhibit the growth of 4T1 breast cancer cells with an IC50 of ∼84.19 ± 25.96 µg/ml after 72 h treatment. Overall, it can be concluded that the green synthesized SeNPs can be attractive, nontoxic, and eco-friendly candidates for drug delivery or medicinal applications.

Keywords: Vaccinium arctostaphylos L.; breast cancer; cytotoxicity; green synthesis; selenium nanoparticles.

MeSH terms

  • Arctostaphylos*
  • Breast Neoplasms* / drug therapy
  • Female
  • Fruit
  • Humans
  • Metal Nanoparticles* / chemistry
  • Nanoparticles* / chemistry
  • Plant Extracts / chemistry
  • Plant Extracts / pharmacology
  • Selenium* / chemistry
  • Selenium* / pharmacology
  • Vaccinium*

Substances

  • Plant Extracts
  • Selenium